Related Experiment Video
Updated: Jun 20, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Role of TL1A in the pathogenesis of rheumatoid arthritis
Jun Zhang1, Xuehai Wang, Hassan Fahmi
1Research Center, Entre Hospitalier de l'Université de Montréal, Notre-Dame Hospital, Montreal, Quebec, Canada.
Insights
Tumor necrosis factor-like ligand 1A (TL1A) worsens collagen-induced arthritis in mice by increasing autoantibody production and Th17 cell differentiation. Elevated TL1A in rheumatoid arthritis suggests a role in disease pathogenesis.
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Background:
- Tumor necrosis factor-like ligand 1A (TL1A) is a cytokine that binds to DR3 and DcR3.
- TL1A is produced by various immune cells, including T cells, monocytes, and dendritic cells.
Purpose of the Study:
- To investigate the role of TL1A in the pathogenesis of collagen-induced arthritis (CIA) in mice.
- To explore the mechanisms by which TL1A influences immune responses relevant to rheumatoid arthritis (RA).
Main Methods:
- Administration of TL1A in a mouse model of CIA.
- Assessment of clinical scores, pathology, autoantibody titers, and cytokine production.
- In vitro studies on T cell differentiation and cytokine production.
- Measurement of TL1A levels in human RA synovial fluids.
Main Results:
- TL1A administration aggravated CIA, increasing disease severity and autoantibody production.
- TL1A enhanced T helper 17 (Th17) cell differentiation and interleukin-17 (IL-17) production.
- Elevated TL1A levels were found in human RA synovial fluids, with chondrocytes and synovial fibroblasts producing TL1A upon stimulation.
Conclusions:
- TL1A plays a significant role in the pathogenesis of RA by promoting autoantibody production and Th17 responses.
- TL1A may contribute to RA initiation and progression through a self-perpetuating inflammatory cycle within the joints.
Abstract:
TNF-like ligand 1A (TL1A), a member of the TNF superfamily, is the ligand of DR3 and DcR3. Several types of cells, such as endothelial cells, monocytes/macrophages, dendritic cells, and CD4 and CD8 T cells, are capable of producing this cytokine. In present study, we demonstrated that TL1A aggravated collagen-induced arthritis in mice. It increased collagen-induced arthritis penetrance and clinical scores as well as the severity of the pathological findings. TL1A administration led to the occurrence of multiple enlarged germinal centers in the spleen, and it boosted serum anti-collagen Ab titers in vivo. In vitro, TL1A augmented TNF-alpha production by T cells upon TCR ligation, and it greatly enhanced Th17 differentiation and IL-17 production. We further showed that human rheumatoid arthritis (RA) synovial fluids had elevated TL1A titers, and human chrondrocytes and synovial fibroblasts were capable of secreting TL1A upon TNF-alpha or IL-1beta stimulation. Taken together, these data suggest that TL1A secretion in lymphoid organs might contribute to RA initiation by promoting autoantibody production, and TL1A secretion stimulated by inflammatory cytokines in RA joints might be a part of a vicious circle that aggravates RA pathogenesis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
TGF - β Signaling Pathway